Showing results (101-110 of 144) with videos related to
Sort By:
Pageof 15
Transplantation|November 11, 2022
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant RecipientsTammy Hod, Aharon Ben-David, Eytan Mor, et al.Journal of Hepatology|April 22, 2022
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipientsYana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 10, 2019
Epidemiologic and phylogenetic analysis of the 2018 West Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage IYaniv Lustig, Ruslan Gosinov, Neta Zuckerman, et al.The Journal of Infection|March 16, 2025
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approachRodolfo Katz, Nguyen Minh Nam, Tulio de Lima Campos, et al.Vaccines|May 7, 2025
Neutralizing Antibody Response to the AreXvy Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients: Assessment Against Reference and Seasonal StrainsLiran Levy, Dafna Yahav, Mark Benzimra, et al.Vaccines|August 28, 2021
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452ROrna Mor, Michal Mandelboim, Shay Fleishon, et al.Viruses|January 8, 2025
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort StudyGili Joseph, Ili Margalit, Yael Weiss-Ottolenghi, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 16, 2022
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variantYael Peled, Arnon Afek, Yitshak Kreiss, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2022
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022Noam Barda, Michal Canetti, Mayan Gilboa, et al.Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.Pageof 15